Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein in Type 2 Diabetes with Secondary Failure to Metformin
NCT03208309Phase 2Completed
- Sponsor
- ANS Pharma
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of diacerein in type 2 diabetes mellitus (T2DM), sponsored by ANS Pharma. Started Jan 2013; status: completed.
02
Drugs
diacerein
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03208309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208309.